Diagnostic and Prognostic Performance of ELF results (DAPPER)

  • Research type

    Research Study

  • Full title

    A prospective cohort study of diagnostic and prognostic biomarkers of alcohol related liver disease

  • IRAS ID

    245793

  • Contact name

    William Rosenberg

  • Contact email

    william.rosenberg@nhs.net

  • Sponsor organisation

    Royal Free London NHS Foundation Trust

  • Duration of Study in the UK

    12 years, 0 months, 1 days

  • Research summary

    The Enhanced Liver Fibrosis (ELF) test is a non-invasive assessment of liver fibrosis, currently recommended by the UK National Institute for Health and Care Excellence in the evaluation of patients with non-alcoholic fatty liver disease. We will perform the ELF test on patients admitted to hospital with Alcohol Related Liver Disease (ARLD) at the time of liver biopsy to determine the diagnostic performance of ELF in the assessment of liver fibrosis and the prognostic performance of ELF in the setting of acute presentations of ARLD. Consecutive patients undergoing liver biopsy for ARLD will have blood samples taken on the day of biopsy, at 30 days or at discharge, at 90 days after biopsy and at 1 year after biopsy. A nested cohort of 10 patients with alcoholic hepatitis will have their residual blood samples used to complete regular ELF tests during their inpatient stay. Data relating to alcohol consumption will be recorded for 90 days and patient records will be electronically linked for long-term follow up.

    ELF test scores will be measured using the Siemens Advia Centaur platform. Liver biopsies will be assessed by a single liver pathologist. Long-term outcome data will be gathered through NHS digital. Statistical tests will be used to determine the diagnostic and prognostic performance of ELF for fibrosis assessment. The performance of ELF will be compared with histological scores of liver fibrosis and biochemical and haematological indices of liver fibrosis including AST to platelet ratio index.

  • REC name

    North West - Haydock Research Ethics Committee

  • REC reference

    18/NW/0396

  • Date of REC Opinion

    18 Jun 2018

  • REC opinion

    Favourable Opinion